Amylin peptides and derivatives and uses thereof

The disclosure relates to an amylin polypeptide conjugate comprising a polypeptide component linked to a duration enhancing moiety. The duration enhancing moiety is linear polyethylene glycol. The disclosure also relates to the use of such a conjugate for the treatment of eating disorder, insulin re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SUN CHENGZAO, SAMANT MANOJ P, NERAVETLA SWETHA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SUN CHENGZAO
SAMANT MANOJ P
NERAVETLA SWETHA
description The disclosure relates to an amylin polypeptide conjugate comprising a polypeptide component linked to a duration enhancing moiety. The duration enhancing moiety is linear polyethylene glycol. The disclosure also relates to the use of such a conjugate for the treatment of eating disorder, insulin resistance, obesity, overweight, abnormal postprandial hyperglycemia, Type I diabetes, Type II diabetes, gestational diabetes, metabolic syndrome, dumping syndrome, hypertension, dyslipidemia, cardiovascular disease, hyperlipidemia, sleep apnea, cancer, pulmonary hypertension, cholescystitis, osteoarthritis, or short bowel syndrome. The polypeptide has the following sequence: Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Xaa-Ser-Ser-Xaa-Asn-Phe-Xaa- Xaa-Xaa-Xaa-Xaa-Lys-Thr-Xaa-Val-Gly-Lys-Lys-Thr-Tyr-X wherein X and the various Xaa groups are defined in the specification
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ618526A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ618526A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ618526A3</originalsourceid><addsrcrecordid>eNrjZDBwzK3MycxTKEgtKMlMSS1WSMxLUUhJLcosSyzJLIPyS4uBjJKM1KLU_DQeBta0xJziVF4ozc0g5-Ya4uyhm1qQH59aXJCYnJqXWhLvF2VmaGFqZOZoTFABAHO1Klg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Amylin peptides and derivatives and uses thereof</title><source>esp@cenet</source><creator>SUN CHENGZAO ; SAMANT MANOJ P ; NERAVETLA SWETHA</creator><creatorcontrib>SUN CHENGZAO ; SAMANT MANOJ P ; NERAVETLA SWETHA</creatorcontrib><description>The disclosure relates to an amylin polypeptide conjugate comprising a polypeptide component linked to a duration enhancing moiety. The duration enhancing moiety is linear polyethylene glycol. The disclosure also relates to the use of such a conjugate for the treatment of eating disorder, insulin resistance, obesity, overweight, abnormal postprandial hyperglycemia, Type I diabetes, Type II diabetes, gestational diabetes, metabolic syndrome, dumping syndrome, hypertension, dyslipidemia, cardiovascular disease, hyperlipidemia, sleep apnea, cancer, pulmonary hypertension, cholescystitis, osteoarthritis, or short bowel syndrome. The polypeptide has the following sequence: Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Xaa-Ser-Ser-Xaa-Asn-Phe-Xaa- Xaa-Xaa-Xaa-Xaa-Lys-Thr-Xaa-Val-Gly-Lys-Lys-Thr-Tyr-X wherein X and the various Xaa groups are defined in the specification</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150925&amp;DB=EPODOC&amp;CC=NZ&amp;NR=618526A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150925&amp;DB=EPODOC&amp;CC=NZ&amp;NR=618526A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SUN CHENGZAO</creatorcontrib><creatorcontrib>SAMANT MANOJ P</creatorcontrib><creatorcontrib>NERAVETLA SWETHA</creatorcontrib><title>Amylin peptides and derivatives and uses thereof</title><description>The disclosure relates to an amylin polypeptide conjugate comprising a polypeptide component linked to a duration enhancing moiety. The duration enhancing moiety is linear polyethylene glycol. The disclosure also relates to the use of such a conjugate for the treatment of eating disorder, insulin resistance, obesity, overweight, abnormal postprandial hyperglycemia, Type I diabetes, Type II diabetes, gestational diabetes, metabolic syndrome, dumping syndrome, hypertension, dyslipidemia, cardiovascular disease, hyperlipidemia, sleep apnea, cancer, pulmonary hypertension, cholescystitis, osteoarthritis, or short bowel syndrome. The polypeptide has the following sequence: Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Xaa-Ser-Ser-Xaa-Asn-Phe-Xaa- Xaa-Xaa-Xaa-Xaa-Lys-Thr-Xaa-Val-Gly-Lys-Lys-Thr-Tyr-X wherein X and the various Xaa groups are defined in the specification</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBwzK3MycxTKEgtKMlMSS1WSMxLUUhJLcosSyzJLIPyS4uBjJKM1KLU_DQeBta0xJziVF4ozc0g5-Ya4uyhm1qQH59aXJCYnJqXWhLvF2VmaGFqZOZoTFABAHO1Klg</recordid><startdate>20150925</startdate><enddate>20150925</enddate><creator>SUN CHENGZAO</creator><creator>SAMANT MANOJ P</creator><creator>NERAVETLA SWETHA</creator><scope>EVB</scope></search><sort><creationdate>20150925</creationdate><title>Amylin peptides and derivatives and uses thereof</title><author>SUN CHENGZAO ; SAMANT MANOJ P ; NERAVETLA SWETHA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ618526A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SUN CHENGZAO</creatorcontrib><creatorcontrib>SAMANT MANOJ P</creatorcontrib><creatorcontrib>NERAVETLA SWETHA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SUN CHENGZAO</au><au>SAMANT MANOJ P</au><au>NERAVETLA SWETHA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Amylin peptides and derivatives and uses thereof</title><date>2015-09-25</date><risdate>2015</risdate><abstract>The disclosure relates to an amylin polypeptide conjugate comprising a polypeptide component linked to a duration enhancing moiety. The duration enhancing moiety is linear polyethylene glycol. The disclosure also relates to the use of such a conjugate for the treatment of eating disorder, insulin resistance, obesity, overweight, abnormal postprandial hyperglycemia, Type I diabetes, Type II diabetes, gestational diabetes, metabolic syndrome, dumping syndrome, hypertension, dyslipidemia, cardiovascular disease, hyperlipidemia, sleep apnea, cancer, pulmonary hypertension, cholescystitis, osteoarthritis, or short bowel syndrome. The polypeptide has the following sequence: Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Xaa-Ser-Ser-Xaa-Asn-Phe-Xaa- Xaa-Xaa-Xaa-Xaa-Lys-Thr-Xaa-Val-Gly-Lys-Lys-Thr-Tyr-X wherein X and the various Xaa groups are defined in the specification</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ618526A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Amylin peptides and derivatives and uses thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T23%3A45%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SUN%20CHENGZAO&rft.date=2015-09-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ618526A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true